Current Rheumatology Reports

, Volume 3, Issue 3, pp 240–244

Osteoporosis in men: Are we ready to diagnose and treat?

Authors

  • Horace M. PerryIII
    • Division of GeriatricsSt. Louis VA Medical Center
  • John E. Morley
    • Division of GeriatricsSt. Louis VA Medical Center
Article

DOI: 10.1007/s11926-001-0024-3

Cite this article as:
Perry, H.M. & Morley, J.E. Curr Rheumatol Rep (2001) 3: 240. doi:10.1007/s11926-001-0024-3

Abstract

Because osteoporosis and its attendant fractures are more common in women than in men, most studies have been performed in women. However, age-related osteoporosis and fragility fractures are also a major problem in men. Recent studies suggest that diagnosing men as osteoporotic when they fall more than 2.5 standard deviations below the mean for young men identifies a group at risk for fracture. Data suggest that many men with femoral fractures have age-related hypogonadism. Hypogonadism is associated with decreased lean body mass and bone mass. Most men with femoral fractures are reported to be hypogonadal. Testosterone replacement in hypogonadal older men improves bone mass and lean body mass. A therapeutic intervention to reduce fracture incidence in men with osteoporosis has been reported. No population-based study has examined the incidence or prevalence of hypogonadism with or without osteoporosis in men. Thus, osteoporosis in men probably exists with and without hypogonadism. Therapeutic interventions should be based on treatment of hypogonadism when present with osteoporosis.

Download to read the full article text

Copyright information

© Current Science Inc 2001